Evidence map›Paper›PMID 31663279›Full record

ArticleOrthopaedic surgery2019

Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.

Runzhi Huang, Zhao Sun, Huimin Zheng, Penghui Yan, Peng Hu, Huabin Yin, Jie Zhang, Tong Meng, Zongqaing Huang

Open access · goldAbstract read
In one paragraph

Article in Orthopaedic surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Runzhi HuangDepartment of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhao SunDepartment of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Huimin ZhengDepartment of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Penghui YanDepartment of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Peng HuDepartment of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Huabin YinDepartment of Orthopedics, Shanghai Bone Tumor Institute, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Jie ZhangShanghai East Hospital, Key Laboratory of Arrhythmias, Ministry of Education, Tongji University School of Medicine, Shanghai, China.
Tong MengDivision of Spine Surgery, Department of Orthopaedics, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Zongqaing HuangDepartment of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID https://orcid.org/0000-0002-2787-1629
First Affiliated Hospital of Zhengzhou University · CNTongji University · CNShanghai Cancer Institute · CN

Funding

Henan medical science and technology research project 201602031National Natural Science Foundation of China 81501203National Natural Science Foundation of China 81702659National Natural Science Foundation of China 81772856Youth Fund of Shanghai Municipal Health Planning Commission 2017YQ054
6 · The paper itself

Abstract

objectiveTo identify prognostic factors and establish nomograms for predicting overall survival (OS) and cause specific survival (CSS) of patients with non-metastatic chondrosarcoma.

methodsWe collected information on patients with non-metastatic chondrosarcoma from the Surveillance, Epidemiology, and End Results (SEER) database between 2005 and 2014, together with data from the First Affiliated Hospital of Zhengzhou University from 2011 to 2016. Variables including patients' baseline demographics (age, race, and gender), tumor characteristics (tumor size and extension, histology subtype, primary site, and American Joint Committee on Cancer [AJCC] stage), therapy (surgery, chemotherapy, and radiotherapy), and socioeconomic status (SES) were extracted for further analysis. OS and CSS were retrieved as our researching endpoints. Patients from the database were regarded as the training set, and univariate analysis, Lasso regression and multivariate analysis as well as the random forest were used to explore the predictors and establish nomograms. To validate nomograms internally and externally, we applied bootstrapped validation internally with the training dataset, while the dataset for external validation was obtained from the First Affiliated Hospital of Zhengzhou University. We estimated the discriminative ability of nomograms based on Cox proportional hazard regression models by means of calibration curves and the concordance index (C-index) of internal and external validation.

resultsAfter the implementation of exclusion criteria, there were 1267 patients in the training set and 72 patients in the testing set with non-metastatic chondrosarcomas. Age, gender, grade, histological subtype, primary site, surgery, radiation, chemotherapy, being employed/unemployed, tumor size, and tumor extension were significantly associated with prognosis in the univariate analysis. Age, gender, tumor size and extension, primary site, surgery, radiotherapy, chemotherapy, histological grade, and subtype were independent prognostic factors in the Cox models. The C-index of nomograms (internal: OS, 0.787; CSS, 0.821; external: OS, 0.777; CSS, 0.821) were higher than following conventional systems: AJCC sixth (OS, 0.640; CSS, 0.673) and seventh edition (OS, 0.675; CSS, 0.711).

conclusionsAge, gender, tumor size and extension, surgery, histological grade, and subtype were independent prognostic factors for both OS and CSS. In addition, we revealed that chondrosarcomas in the trunk, radiotherapy, and chemotherapy were correlated with poor prognosis. Our nomograms based on significant clinicopathologic features can well predict the 3-year and 5-year survival probability of patients with non-metastatic chondrosarcoma and assist oncologists in making accurate survival evaluation.

Indexed as

SEER ProgramSurvival RateAdolescentAdultAgedAged, 80 and overBone NeoplasmsChildChild, PreschoolChondrosarcomaFemaleHumansMaleMiddle AgedNeoplasm GradingNeoplasm StagingBone cancerChondrosarcomaNon-metastaticPrognostic factorSurvival analysis

Identifiers

PMID31663279
PMCPMC6819193
OpenAlexW2982704188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.